American Society of Addiction Medicine

This Week in Addiction Medicine from ASAM

American Society of Addiction Medicine

  • Lead: Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits

Lead: Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits

Tuesday 24th June 2025

Explore benzodiazepine tapering guidelines and their implications for addiction medicine in this engaging episode.
7 minutes
Informative
Supportive
Educational
Compassionate
Encouraging

About this podcast

This Week in Addiction Medicine from ASAM
Author:
American Society of Addiction Medicine
Overview:
Categories:
Innovative Treatments & Recovery Paths
Navigating Alcohol Dependency
Family Recovery from Addiction
Nutritional Pathways to Recovery
Navigating Intimate Relationships
Links:
Visit site
Rounded Button Dark
Do you want to link to this podcast?
Get the buttons here!

Benzodiazepine Tapering: Balancing Risks and Benefits

Episode Overview

  • Personalised tapering strategies are crucial for benzodiazepine users.
  • Avoid abrupt discontinuation to prevent withdrawal symptoms.
  • Shared decision-making enhances patient safety during tapering.
  • Cannabis use is linked to increased cardiovascular risks.
  • Telehealth serves higher-risk patients without increasing misuse.
"Tapering strategies should be personalised and adjusted based on the patient's response."
This episode of 'This Week in Addiction Medicine' tackles the crucial topic of benzodiazepine tapering guidelines. The American Society of Addiction Medicine (ASAM), alongside other medical bodies, has crafted evidence-based recommendations to help clinicians make informed decisions about tapering these medications. The focus is on balancing risks and benefits, with a clear message that abrupt discontinuation should be avoided due to potential withdrawal risks.
Instead, a personalised approach is encouraged, taking into account each patient's unique response and providing psychosocial support throughout the process. You'll find insights into how shared decision-making can empower patients and ensure their safety during tapering. Additionally, the episode explores studies on cannabis use and cardiovascular risks, prescription misuse in telehealth settings, and cognitive behavioural interventions for co-occurring disorders. These discussions are packed with research findings and expert opinions, making them highly relevant for anyone interested in addiction medicine.
The host, Zach Caruso, presents these complex topics with clarity and a touch of light humour, making it accessible even if you're not a medical professional. The conversation also touches on the need for increased oversight of social media algorithms due to their addictive nature, drawing parallels to substance use disorders. If you're curious about the latest in addiction medicine or want to understand the implications of benzodiazepine tapering, this episode is a must-listen.
It offers valuable perspectives and practical advice that can be life-changing for patients and healthcare providers alike.
alcoholfree.com
Published by The Mindful Drinking Company Limited
4 Providence Court, Pynes Hill, Exeter, Devon, EX2 5JL, England
Registered in England and Wales.
Company Number: 1195057. Vat Number: GB320915135.
Registered address as above.
© Copyright 2005-2025 The Mindful Drinking Company Limited.
All Rights Reserved.
alcoholfree.com is a participant in the Amazon Associates Programme, an affiliate advertising programme designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.co.uk. As an Amazon Associate, we earn from qualifying purchases.